Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC‐ADNI project-Reference-Cited by-同舟云学术

Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC‐ADNI project

Published:2014-09-14 Issue:2 Volume:11 Page:151
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Bocchetta Martina¹²,Boccardi Marina¹,Ganzola Rossana³,Apostolova Liana G.⁴,Preboske Gregory⁵,Wolf Dominik⁶,Ferrari Clarissa⁷,Pasqualetti Patrizio⁸⁹,Robitaille Nicolas³,Duchesne Simon³,Jack Clifford R.⁵,Frisoni Giovanni B.¹¹⁰,Bartzokis George¹²³⁴⁵,DeCarli Charles¹²³⁴⁵,deToledo‐Morrell Leyla¹²³⁴⁵,Fellgiebel Andreas¹²³⁴⁵,Firbank Michael¹²³⁴⁵,Gerritsen Lotte¹²³⁴⁵,Henneman Wouter¹²³⁴⁵,Killiany Ronald J.¹²³⁴⁵,Malykhin Nikolai¹²³⁴⁵,Pruessner Jens C.¹²³⁴⁵,Soininen Hilkka¹²³⁴⁵,Wang Lei¹²³⁴⁵,Watson Craig¹²³⁴⁵,Wolf Henrike¹²³⁴⁵,

Affiliation:

1. LENITEM (Laboratory of Epidemiology, Neuroimaging and Telemedicine), IRCCS‐Centro S. Giovanni di Dio‐Fatebenefratelli BresciaBresciaItaly

2. Department of Molecular and Translational MedicineUniversity of BresciaBresciaItaly

3. Department of RadiologyUniversité Laval and Centre de Recherche de l'Institut universitaire de santé mentale de QuébecQuebec CityCanada

4. Mary S. Easton Center for Alzheimer's Disease Research and Laboratory of NeuroImaging, David Geffen School of Medicine, University of CaliforniaLos AngelesLos AngelesCAUSA

5. Department of Diagnostic RadiologyMayo Clinic and FoundationRochesterMNUSA

6. Klinik für Psychiatrie und PsychotherapieJohannes Gutenberg‐Universität MainzMainzGermany

7. IRCCS‐Centro S. Giovanni di Dio‐Fatebenefratelli BresciaBresciaItaly

8. SeSMIT (Service for Medical Statistics and Information Technology)AFaR (Fatebenefratelli Association for Research)Fatebenefratelli HospitalRomeItaly

9. Unit of Clinical and Molecular EpidemiologyIRCCS “San Raffaele Pisana, ”RomeItaly

10. Memory Clinic and LANVIE ‐ Laboratory of Neuroimaging of AgingUniversity Hospitals and University of GenevaGenevaSwitzerland

Funder

Wyeth

Eli Lilly and Company

Alzheimer's Association

Alzheimer's Disease Neuroimaging Initiative

National Institutes of Health

Abbott Fund

Alzheimer's Drug Discovery Foundation

Amorfix Life Sciences

AstraZeneca

Bayer HealthCare

BioClinica

Biogen Idec

Bristol-Myers Squibb

Eisai

Roche

Genentech

GE Healthcare

Innogenetics

Janssen Research and Development

Medpace

Merck

Meso Scale Diagnostics

Novartis Pharmaceuticals Corporation

Pfizer

Servier

Synarc

Takeda Pharmaceutical Company

Canadian Institutes of Health Research

Foundation for the National Institutes of Health

Lilly

ADNI

Abbott

Amorfix Life Sciences Ltd

BioClinica, Inc

Biogen Idec Inc

Bristol-Myers Squibb Company

Eisai Inc

Elan Pharmaceuticals Inc

F. Hoffmann-La Roche Ltd

Genentech, Inc

N.V.; IXICO Ltd

Janssen Alzheimer Immunotherapy Research & Development, LLC

Johnson & Johnson Pharmaceutical Research & Development, LLC

Medpace, Inc

Merck & Co., Inc

Meso Scale Diagnostics, LLC

Pfizer Inc

Synarc Inc

Ministère du Développement Économique

de l'Innovation et de l'Exportation du Québec

Fonds de Recherche Québec-Santé

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.12.019

Reference22 articles.

1. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

2. Revising the definition of Alzheimer's disease: a new lexicon;Dubois B.;Lancet Neurol,2010

3. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between acoustic features and brain volumes: the Framingham Heart Study;Frontiers in Dementia;2023-11-23

2. Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer’s disease at CPT1A locus;Clinical Epigenetics;2023-10-27

3. Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study;Journal of Alzheimer's Disease;2023-10-24

4. Relation of MRI-Visible Perivascular Spaces and Other MRI Markers of Cerebral Small Vessel Disease;Brain Sciences;2023-09-14

5. Characterizing age- and sex-related differences in brain structure among middle-aged and older Hispanic/Latino adults in the study of Latinos- investigation of neurocognitive aging magnetic resonance imaging (SOL-INCA MRI);Neurobiology of Aging;2023-06